Ozempic, initially approved for Type 2 diabetes in 2017, has gained popularity as a weight loss drug
Real-world data underscore this: nearly 65% of patients using GLP-1s for weight loss (without diabetes) discontinue within one year, as do about 47% of those with diabetes
Schedule a consultation with the experts at IUVENTUS MEDICAL CENTER today
Anxiety, depression and poor sleep quality as long-term post-COVID sequelae in previously hospitalized patients: A multicenter study
Epithalon is soluble in sterile water, acetic acid, or other aqueous buffers depending on purity and formulation
For instance, administration of UroA to Caenorhabditis elegans led to a significant extension of lifespan, while rodent studies showed enhanced muscle endurance and reduced signs of muscle ageing (Reference Ryu, Mouchiroud and Andreux15)